对甲状腺激素的敏感性受损与非酒精性脂肪肝疾病的发展有关,这种疾病在非甲状腺糖尿病患者中发生
Xiaowen Zhang1,2, Jie Liu3, Qian Wang1,2
1Department of Endocrinology and Metabolism, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, The Affiliated Hospital to Nanjing University Medical School, Nanjing, China.
甲状腺激素敏感性受损会增加糖尿病患者非酒精性脂肪性肝病 (NAFLD) 的风险. 这种敏感性也降低了风险糖尿病患者的晚期纤维化风险,突出了对糖尿病特异性NAFLD研究的需要.
科学领域:
- 内分泌学 在内分泌学.
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
背景情况:
- 对甲状腺激素的获得性耐药性在一般人群中被认可.
- 非酒精性脂肪肝 (NAFLD) 是一个日益严重的健康问题.
- 甲状腺激素敏感性和NAFLD之间的相互作用,特别是在糖尿病患者中,需要进一步研究.
研究的目的:
- 评估甲状腺激素敏感度指数与NAFLD之间的关联.
- 根据糖尿病状况进行分层分析.
- 探索甲状腺激素抵抗与晚期纤维化风险之间的关系.
主要方法:
- 对26,413名健康查参与者和8,246名住院的2型糖尿病患者的分析.
- 甲状腺反量基指数 (TFQI) 的计算,甲状腺刺激激素指数 (TSHI) 和甲状腺素耐药性指数 (TT4RI).
- 使用FIB-4得分和多变量逻辑回归评估晚期纤维化风险.
主要成果:
- 甲状腺反量基指数 (TFQI) 与糖尿病患者的NAFLD风险增加有关 (OR=1.39-1.82),但不是非糖尿病患者 (OR=0.94).
- 糖尿病患者的这种关联主要与NAFLD有关,NAFLD的晚期纤维化概率低 (OR=1.42).
- 在风险糖尿病患者中,TFQI与较低的晚期纤维化风险相关 (OR=0.62),独立于NAFLD存在.
结论:
- 甲状腺激素敏感性受损与糖尿病患者中较高的NAFLD风险有关.
- 甲状腺激素抵抗可能会降低糖尿病患者晚期纤维化风险.
- 未来的NAFLD研究应该考虑基于糖尿病状况的分层分析.
更多相关视频
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
